Company News

Kenvue Publishes Largest Set of Clinical Data on Retinol

Validates the efficacy and tolerability of proprietary 0.1% stabilized retinol.

Author Image

By: Christine Esposito

Editor-in-Chief

Kenvue has released new efficacy and tolerability data published in the April edition of Journal of Drugs in Dermatology supporting 0.1% retinol as the cosmetic solution to target signs of skin aging. The new clinical assessment is the largest to be published in scientific literature on the ingredient. Kenvue has decades of global specialized research in aging skin, including launching the first prescription retinoid in 1971 and being the first to perfect the process of stabilizing retinol an...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters